ReviewFrontiers in pharmacology2026

Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease.

Xiaoling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.